ZIOPHARM ONCOLOGY INC 4
4 · ZIOPHARM ONCOLOGY INC · Filed Apr 14, 2016
Insider Transaction Report
Form 4
Fowler Wyche
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2016-04-04−15,000→ 0 totalExercise: $5.01From: 2006-04-26Exp: 2016-04-26→ Common Stock (15,000 underlying) - Tax Payment
Common Stock
2016-04-04$7.92/sh−11,694$92,616→ 134,310 total - Exercise/Conversion
Common Stock
2016-04-04$5.01/sh+15,000$75,150→ 146,004 total
Footnotes (1)
- [F1]Represents shares withheld to pay the exercise price and withholding tax obligations.